查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1628892

下一代糖尿病治疗和药物传输市场，按产品类型、适应症、人口统计、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Next Generation Diabetes Therapy and Drug Delivery Market, By Product Type, By Indication, By Demographic, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，下一代糖尿病治疗和药物输送市场规模为98.2032亿美元，2024年至2032年复合年增长率为14.29%。

下一代糖尿病治疗与药物传输市场-市场动态

糖尿病盛行率不断上升推动市场需求

全球糖尿病盛行率不断上升，推动了对创新疗法的需求。此外，城市化、不健康饮食和体力活动减少正在促进下一代糖尿病治疗和药物传输市场的成长。然而，高成本和监管挑战可能会阻碍市场成长。相反，开发负担得起的、低副作用的产品和大量未确诊的糖尿病患者为市场提供了巨大的成长机会。此外，连续血糖监测 (CGM) 和胰岛素贴片的发展正在改善糖尿病管理，使治疗更有效、更侵入性。

下一代糖尿病治疗和药物传输市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 14.29% 左右的复合年增长率成长

根据产品类型细分，预计 CGM 系统将在 2023 年显示最大的市场份额

根据适应症细分，第2型糖尿病是2023年的主导细分市场

根据人口细分，2023年成年人口（>14岁）是主导群体

按地区划分，北美是 2023 年的主要收入来源

下一代糖尿病治疗和药物输送市场細項分析：

全球新一代糖尿病治疗和药物传输市场根据产品类型、适应症、人口统计、最终用户和地区进行细分。

根据产品类型，市场分为五类：口服胰岛素、吸入性胰岛素、CGM系统、胰岛素贴片和人工胰臟。 CGM 系统领域主导着市场。这可以归因于这些系统相对于传统糖尿病产品的优势，包括用户友好的功能以及更快、更有效地检测血糖水平变化的能力。

根据适应症，市场分为两类：1 型糖尿病和第 2 型糖尿病。 2 型糖尿病领域在市场上占据主导地位，并可能在预测期内保持其主导地位。部分原因是城市化进程加快、不良饮食和久坐的生活方式导致第 2 型糖尿病盛行率增加。

下一代糖尿病治疗和药物传输市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。

下一代糖尿病治疗与药物输送市场-竞争格局：

由于对更有效、侵入性更小的糖尿病管理的需求不断增长，各公司正在专注于创新解决方案，例如口服和吸入胰岛素、胰岛素贴片和连续血糖监测系统。製造商越来越多地投资于研发，以创造非侵入性、用户友好的产品。策略伙伴关係、与科技公司的合作以及对专业新创公司的收购正在帮助公司增强其产品组合併加速下一代疗法的商业化。

最新进展：

2024 年 6 月，阿斯特捷利康的 Farxiga（达格列净）获得批准，用于改善 10 岁及以上 2 型糖尿病儿科患者的血糖控制。此次批准是在 T2NOW III 期试验取得积极结果之后进行的，标誌着儿科糖尿病治疗取得了重大进展。 Farxiga 先前已被批准用于治疗第 2 型糖尿病成人患者。

目录

第 1 章：下一代糖尿病治疗与药物传递市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按产品类型分類的下一代糖尿病治疗和药物传输市场片段
    • 下一代糖尿病治疗和药物传输市场片段（按适应症）
    • 按人口统计的下一代糖尿病治疗和药物传输市场片段
    • 最终用户的下一代糖尿病治疗和药物传输市场片段
    • 按国家/地区分類的下一代糖尿病治疗和药物传输市场片段
    • 按地区分類的下一代糖尿病治疗和药物传输市场片段
  • 竞争洞察

第 3 章：下一代糖尿病和药物传输主要市场趋势

  • 下一代糖尿病治疗和药物传输市场驱动因素
    • 市场驱动因素的影响分析
  • 下一代糖尿病治疗和药物传输市场限制
    • 市场限制影响分析
  • 下一代糖尿病治疗与药物输送市场机会
  • 下一代糖尿病治疗和药物传输市场的未来趋势

第 4 章：下一代糖尿病与药物输送产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：下一代糖尿病治疗与药物输送市场：地缘政治紧张局势升级的影响

  • COVID-19 大流行的影响
  • 俄罗斯-乌克兰战争的影响
  • 中东衝突的影响

第 6 章：下一代糖尿病治疗与药物输送市场格局

  • 2023 年下一代糖尿病治疗和药物传递市场份额分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：下一代糖尿病治疗和药物传输市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 口服胰岛素
    • 吸入型胰岛素
    • 连续GM系统
    • 胰岛素贴片
    • 人工胰臟

第 8 章：下一代糖尿病治疗和药物传输市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 1 型糖尿病
    • 2 型糖尿病

第 9 章：下一代糖尿病治疗和药物传输市场 - 按人口统计

  • 概述
    • 按人口统计分類的细分市场占有率分析
    • 儿童人口（14 岁）
    • 成人人口（>14 岁）

第 10 章：下一代糖尿病治疗和药物输送市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 家庭医疗保健
    • 重症加护病房
    • 诊断/诊所

第 11 章：下一代糖尿病治疗和药物传输市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美下一代糖尿病和药物传输主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按人口统计）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲下一代糖尿病和药物传输主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按人口统计）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区下一代糖尿病和药物传输主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模与预测（依人口统计）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲下一代糖尿病和药物传输主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模与预测（按人口统计）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲下一代糖尿病和药物传输主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按人口统计）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 下一代糖尿病和药物输送产业

  • 竞争仪表板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • MannKind Corporation
    • Medtronic plc
    • Dexcom, Inc.
    • Novo Nordisk A/S
    • Senseonics Holdings, Inc.
    • Eli Lilly and Company
    • Abbott laboratories
    • Glysens Incorporated
    • Johnson & Johnson
    • Sanofi SA
    • Enteris BioPharma
    • Echo Therapeutics, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4421

REPORT HIGHLIGHT

Next generation diabetes therapy and drug delivery market size was valued at USD 9,820.32 Million in 2023, expanding at a CAGR of 14.29% from 2024 to 2032.

Next-generation diabetes therapy and drug delivery aim to improve the management of blood glucose levels through advanced, less invasive methods. These include oral and inhalable insulin, insulin patches, continuous glucose monitoring (CGM) systems, and artificial pancreas technologies. By reducing the need for needles, these innovations minimize pain and skin irritation, offering patients more convenient, effective, and comfortable solutions for managing their diabetes and adjusting insulin levels based on real-time glucose data.

Next Generation Diabetes Therapy and Drug Delivery Market- Market Dynamics

Growing prevalence of diabetes to propel market demand

The rising global prevalence of diabetes is driving demand for innovative therapies. Besides, urbanization, unhealthy diets, and reduced physical activity are contributing to the growth of the next-generation diabetes therapy and drug delivery market. However, high costs and regulatory challenges may hamper the market growth. On the contrary, development of affordable, low-side-effect products and the large population of undiagnosed diabetic patients present significant growth opportunities for the market. Furthermore, developments in continuous glucose monitoring (CGM) and insulin patches are improving diabetes management, making treatments more efficient and less invasive.

Next Generation Diabetes Therapy and Drug Delivery Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.29% over the forecast period (2024-2032)

Based on product type segmentation, CGM systems was predicted to show maximum market share in the year 2023

Based on indication segmentation, Type 2 diabetes was the leading segment in 2023

Based on demographic segmentation, adult population (>14 years) was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Next Generation Diabetes Therapy and Drug Delivery Market- Segmentation Analysis:

The Global Next Generation Diabetes Therapy and Drug Delivery Market is segmented on the basis of Product Type, Indication, Demographic, End User, and Region.

The market is divided into five categories based on product type: oral insulin, inhalable insulin, CGM systems, insulin patches, and artificial pancreas. The CGM systems sector dominates the market. This can be attributed to the benefits of these systems over traditional diabetes products, including user-friendly features and the ability to detect changes in blood glucose levels more quickly and efficiently.

The market is divided into two categories based on indication: Type 1 diabetes and Type 2 diabetes. The type 2 diabetes sector dominates the market and is likely to maintain its dominance during the forecast period. This is partly due to an increase in the prevalence of type 2 diabetes owing to by increasing urbanization, poor diets, and sedentary lifestyles.

Next Generation Diabetes Therapy and Drug Delivery Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Next Generation Diabetes Therapy and Drug Delivery Market- Competitive Landscape:

Driven by the growing demand for more effective and less invasive diabetes management, companies are focusing on innovative solutions such as oral and inhalable insulin, insulin patches, and continuous glucose monitoring systems. Manufacturers are increasingly investing in research and development to create non-invasive, user-friendly products. Strategic partnerships, collaborations with tech firms, and acquisitions of specialized startups are helping companies enhance their product portfolios and accelerate the commercialization of next-generation therapies.

Recent Developments:

In June 2024, AstraZeneca received approval for its Farxiga (dapagliflozin) for improving glycaemic control in pediatric patients aged 10 and older with type-2 diabetes. This approval follows positive results from the T2NOW Phase III trial, marking a significant development in pediatric diabetes treatment. Farxiga was previously approved for adults with type-2 diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • MannKind Corporation
  • Medtronic plc
  • Dexcom, Inc.
  • Novo Nordisk A/S
  • Senseonics Holdings, Inc.
  • Eli Lilly and Company
  • Abbott laboratories
  • Glysens Incorporated
  • Johnson & Johnson
  • Sanofi S.A.
  • Enteris BioPharma
  • Echo Therapeutics, Inc.
  • Others

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Oral Insulin
  • Inhalable Insulin
  • CGM Systems
  • Insulin Patches
  • Artificial Pancreas

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Type 1 Diabetes
  • Type 2 Diabetes

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY DEMOGRAPHIC- MARKET ANALYSIS, 2019 - 2032

  • Child Population (14 years)
  • Adult Population (<14 years)

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Home Healthcare
  • ICUs
  • Diagnostic/Clinics

GLOBAL NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Next Generation Diabetes Therapy and Drug Delivery Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Product Type
    • 2.1.2. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Indication
    • 2.1.3. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Demographic
    • 2.1.4. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by End User
    • 2.1.5. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Country
    • 2.1.6. Next Generation Diabetes Therapy and Drug Delivery Market Snippet by Region
  • 2.2. Competitive Insights

3. Next Generation Diabetes and Drug Delivery Key Market Trends

  • 3.1. Next Generation Diabetes Therapy and Drug Delivery Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Next Generation Diabetes Therapy and Drug Delivery Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Next Generation Diabetes Therapy and Drug Delivery Market Opportunities
  • 3.4. Next Generation Diabetes Therapy and Drug Delivery Market Future Trends

4. Next Generation Diabetes and Drug Delivery Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Next Generation Diabetes Therapy and Drug Delivery Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Next Generation Diabetes Therapy and Drug Delivery Market Landscape

  • 6.1. Next Generation Diabetes Therapy and Drug Delivery Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Next Generation Diabetes Therapy and Drug Delivery Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Oral Insulin
    • 7.1.3. Inhalable Insulin
    • 7.1.4. CGM Systems
    • 7.1.5. Insulin Patches
    • 7.1.6. Artificial Pancreas

8. Next Generation Diabetes Therapy and Drug Delivery Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
    • 8.1.2. Type 1 Diabetes
    • 8.1.3. Type 2 Diabetes

9. Next Generation Diabetes Therapy and Drug Delivery Market - By Demographic

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Demographic, 2023 & 2032 (%)
    • 9.1.2. Child Population (14 years)
    • 9.1.3. Adult Population (>14 years)

10. Next Generation Diabetes Therapy and Drug Delivery Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 10.1.2. Home Healthcare
    • 10.1.3. ICUs
    • 10.1.4. Diagnostic/Clinics

11. Next Generation Diabetes Therapy and Drug Delivery Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Next Generation Diabetes and Drug Delivery Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Demographic, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Next Generation Diabetes and Drug Delivery Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. MannKind Corporation
    • 12.2.2. Medtronic plc
    • 12.2.3. Dexcom, Inc.
    • 12.2.4. Novo Nordisk A/S
    • 12.2.5. Senseonics Holdings, Inc.
    • 12.2.6. Eli Lilly and Company
    • 12.2.7. Abbott laboratories
    • 12.2.8. Glysens Incorporated
    • 12.2.9. Johnson & Johnson
    • 12.2.10. Sanofi S.A.
    • 12.2.11. Enteris BioPharma
    • 12.2.12. Echo Therapeutics, Inc.
    • 12.2.13. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us